YY1 and cancer: Recent studies also reveal that inhibiting HnRNP L decreases PD‐L1 expression and enhances antitumor immunity by destabilising YY1 mRNA in castration‐resistant prostate cancer (CRPC), thereby promoting T cell‐mediated cancer cell ferroptosis.58